Navigation Links
Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 22, 2008
Date:7/15/2008

Conference Call Scheduled for July 22, 2008 at 11:00 am EASTERN

DUBLIN, Ireland, July 15 /PRNewswire-FirstCall/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of fiscal year 2008 on Tuesday, July 22, 2008. The Company has scheduled a conference call for that same day, Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA: 877-356-5706

International: +1-706-643-0580

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=50024

A replay of the call can be accessed until July 25, 2008 by dialing:

USA: 1-800-642-1687

International: +1-706-645-9291

Conference ID #: 56210288

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=50024

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires, manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website: http://www.trinitybiotech.com.

Contact:

Ms. Niamh Long Joe Diaz, Joe Dorame and Robert Blum

Trinity Biotech plc Lytham Partners, LLC

Investor Relations Officer 602-889-7900

(800) 603-8076


'/>"/>
SOURCE Trinity Biotech plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
3. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
4. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
5. N.C. Biotech Center Launches Larger Loans
6. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
7. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
8. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
9. Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video
10. N.C. Biotechnology Center Launches Industrial Fellowship Program
11. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... One Million Solutions in Health ... million in investment towards 15+ TEC Validation Projects™. As a pre-competitive consortium, ... in drug safety assessment, for the industry as a whole. , Through the ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court of New ... the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company (DPCL) for ... one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary Dishman USA ...
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
Breaking Biology News(10 mins):